NASDAQ:HAPP - Happiness Biotech Group Stock Price, Forecast & News

Happiness Biotech Group trades on the NASDAQ under the ticker symbol "HAPP."

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Happiness Biotech Group in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Happiness Biotech Group.

Press coverage about HAPP stock has trended somewhat negative recently, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Happiness Biotech Group earned a coverage optimism score of -1.9 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future. View News Stories for Happiness Biotech Group.

Some companies that are related to Happiness Biotech Group include Canopy Rivers (RIV), Chromadex (CDXC), Sundial Growers (SNDL), Foamix Pharmaceuticals (FOMX), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN), True Drinks (TRUU), FitLife Brands (FTLF), GLG Life Tech (GLGLF), Nutra Pharma (NPHC), Tauriga Sciences (TAUG), Entia Biosciences (ERGO) and Beleave (BE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Happiness Biotech Group investors own include PIMCO Corporate&Income Opportunity Fund (PTY), NuStar Energy (NS), Blackrock Coporate High Yield Fund (HYT), BlackRock Debt Strategies Fund (DSU), Citigroup (C), Blackstone Group (BX), BlackRock Science & Technology Trust (BST), Aurora Cannabis (ACB), Western Digital (WDC) and Manhattan Bridge Capital (LOAN).

(HAPP) raised $11 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 2,000,000 shares at $5.50 per share. Univest Securities served as the underwriter for the IPO and WestPark Capital, Newbridge Securities and Zivest Global were co-managers.

Happiness Biotech Group's lock-up period expires on Wednesday, April 22nd. Happiness Biotech Group had issued 2,000,000 shares in its initial public offering on October 25th. The total size of the offering was $11,000,000 based on an initial share price of $5.50. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the expiration of the lock-up period.

Shares of HAPP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of HAPP stock can currently be purchased for approximately $4.72.

Happiness Biotech Group has a market capitalization of $117.91 million. View Additional Information About Happiness Biotech Group.

The official website for Happiness Biotech Group is http://www.fjxfl.com/.

Happiness Biotech Group's mailing address is NO. 11 DONGJIAO EAST ROAD SHUANGXI SHUNCHANG, NANPING F4, 353001. The company can be reached via phone at 86-059-9782-8808.